Royal London Asset Management LTD Jazz Pharmaceuticals PLC Transaction History

Royal London Asset Management LTD

$39.4 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$103.94 - $118.98 $126,287 - $144,560	1,215 Added 5.34%	23,978 $2.56 Million
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $54,254 - $62,534	-471 Reduced 2.03%	22,763 $2.74 Million
Q4 2023 Feb 13, 2024	SELL	$114.26 - $136.0 $4,570 - $5,440	-40 Reduced 0.17%	23,234 $2.86 Million
Q3 2023 Nov 14, 2023	BUY	$122.0 - $145.31 $249,978 - $297,740	2,049 Added 9.65%	23,274 $3.01 Million
Q2 2023 Aug 11, 2023	BUY	$122.5 - $147.16 $221,357 - $265,918	1,807 Added 9.31%	21,225 $2.63 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $272,381 - $326,235	2,033 Added 11.69%	19,418 $2.84 Million
Q4 2022 Feb 09, 2023	SELL	$129.72 - $159.85 $52,147 - $64,259	-402 Reduced 2.26%	17,385 $2.77 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $436,482 - $555,748	-3,448 Reduced 16.24%	17,787 $2.37 Million
Q2 2022 Aug 12, 2022	BUY	$141.59 - $168.66 $16,424 - $19,564	116 Added 0.55%	21,235 $3.31 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $114,601 - $142,058	884 Added 4.37%	21,119 $3.29 Million
Q4 2021 Oct 18, 2022	BUY	$119.87 - $145.67 $251,607 - $305,761	2,099 Added 11.57%	20,235 $2.58 Million
Q4 2021 Jan 18, 2022	BUY	$119.87 - $145.67 $251,607 - $305,761	2,099 Added 11.57%	20,235 $2.58 Million
Q3 2021 Oct 18, 2022	BUY	$128.64 - $184.79 $100,725 - $144,690	783 Added 4.51%	18,136 $2.36 Million
Q3 2021 Nov 02, 2021	BUY	$128.64 - $184.79 $100,725 - $144,690	783 Added 4.51%	18,136 $2.36 Million
Q2 2021 Oct 18, 2022	SELL	$160.2 - $186.42 $621,896 - $723,682	-3,882 Reduced 18.28%	17,353 $3.08 Million
Q1 2021 Oct 17, 2022	SELL	$150.19 - $173.5 $583,037 - $673,527	-3,882 Reduced 18.28%	17,353 $2.85 Million
Q4 2020 Jan 29, 2021	SELL	$140.71 - $165.05 $611,384 - $717,142	-4,345 Reduced 20.02%	17,353 $2.87 Million
Q2 2020 Jul 31, 2020	SELL	$95.68 - $121.88 $299,765 - $381,850	-3,133 Reduced 12.62%	21,698 $2.38 Million
Q3 2019 Nov 12, 2019	BUY	$125.18 - $143.24 $3.11 Million - $3.56 Million	24,831 New	24,831 $3.18 Million
Q2 2019 Jul 31, 2019	SELL	$125.55 - $144.48 $2.85 Million - $3.27 Million	-22,667 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$121.81 - $142.95 $352,518 - $413,697	-2,894 Reduced 11.32%	22,667 $0
Q4 2018 Jan 29, 2019	SELL	$115.94 - $166.74 $3.6 Million - $5.17 Million	-31,011 Reduced 54.82%	25,561 $3.11 Million
Q3 2018 Nov 08, 2018	BUY	$161.01 - $180.57 $4.97 Million - $5.58 Million	30,897 Added 120.34%	56,572 $0
Q2 2018 Sep 19, 2018	BUY	$146.33 - $183.18 $3.76 Million - $4.7 Million	25,675 New	25,675 $4.42 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account